246 related articles for article (PubMed ID: 12196370)
1. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
2. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
4. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
5. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
6. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
[TBL] [Abstract][Full Text] [Related]
7. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
Dieterle CP; Conzelmann M; Linnemann U; Berger MR
Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
[TBL] [Abstract][Full Text] [Related]
8. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
[TBL] [Abstract][Full Text] [Related]
9. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
11. Frequency and clinicopathology associations of K-ras mutations in colorectal cancer in a northeast Mexican population.
Martinez-Garza SG; Núñez-Salazar A; Calderon-Garcidueñas AL; Bosques-Padilla FJ; Niderhauser-García A; Barrera-Saldaña HA
Dig Dis; 1999; 17(4):225-9. PubMed ID: 10754362
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
[TBL] [Abstract][Full Text] [Related]
14. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
15. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
[TBL] [Abstract][Full Text] [Related]
16. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
[TBL] [Abstract][Full Text] [Related]
17. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer.
Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN
Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179
[TBL] [Abstract][Full Text] [Related]
18. Association of K-ras mutations with liver metastases from colorectal carcinoma.
Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
[TBL] [Abstract][Full Text] [Related]
19. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
[TBL] [Abstract][Full Text] [Related]
20. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]